Theratechnologies Stock Plummets On Disappointing Q1 Earnings, Full Year Forecast: Retail Sentiment Sours
For the fiscal year 2025, the company estimates revenue in the range of $80 million to $83 million and adjusted EBITDA to be between $10 and $12 million.